P177 EFFECTS OF PRE-OPERATIVE USE OF BIOLOGIC AGENTS ON INTRA-OPERATIVE BLOOD LOSS, OPERATIVE TIME AND LENGTH OF SMALL BOWEL RESECTION IN CROHN'S DISEASE PATIENTS

Authors :: Atif Iqbal
Fares Ayoub
Sanda A. Tan
Sarah C. Glover
Naueen A. Chaudhry
Ellen M. Zimmermann
Amir Y. Kamel
Source :: Gastroenterology. 154:S95-S96
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
Crohn's disease
Small bowel resection
Intra operative
Hepatology
business.industry
Gastroenterology
medicine.disease
Pre operative
Surgery
Vedolizumab
Natalizumab
Blood loss
medicine
Operative time
business
medicine.drug

Full Text Access

Tools